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Background: The reuse of implant healing abutments is common in dental practice. Effective elimination of bac-
teria and viruses is accomplished by conventional sterilization. 
The aim of this work was to explore the eventual survival of microorganisms on sterilized healing abutments and 
to rule out the presence of transmissible organic material after standard procedures. 
Material and Methods: A total of 55 healing abutments previously used in patients will be washed and sterilized 
in a steam autoclave at 121ºC for 15 min. Each healing abutment will be cultured in Brain Heart Infusion broth 
(BHI) under strict aseptic conditions. Besides, two control groups will be included: one of 3 unused healing abut-
ments, and the other of just medium. After 10 days at 37°C under a 5% CO2 100 µl of the broth will be plated on 
solid media (Brain Infusion Agar, BHIA) and Columbia Blood agar to test for sterility. The remaining volume will 
be centrifuged, the sediment fixed, and a Gram stain performed to discard the presence of non-cultivable micro-
organisms. Moreover, to determine the presence of remaining organic material after the cleaning and sterilizing 
treatments, the bioburden will be determined by measuring total organic carbon (TOC) in another 10 previously 
used healing abutments, cleaned and sterilized, that will be submerged in Milli-Q water and sonicated. 
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Introduction
The reuse of implant abutments is common practice, 
as it reduces costs for both patients and dentists. Since 
abutments are mostly made of titanium, it has been as-
sumed that autoclave sterilization guarantees the safety 
of such reuse, although it can alter the composition of 
the surface due to atmospheric pollutants, especially 
when the sterilization process is repeated several times 
(1).
Abutments should favor the maturation of peri-implant 
tissues during osseointegration, favouring the modeling 
of soft tissues surrounding the implant. Moreover, the 
attachment of soft tissue around the implant abutments 
takes place through the establishment of a hemidesmo-
somal junction involving inflammatory cells (about 3 
mm thickness) that contributes to osseointegration.
Prevention of the presence of bacteria in the region to-
gether with the use of sterile instruments and compo-
nents to avoid cross-infection between patients are pri-
mary goals of implantology. Thus, despite the common 
practice of reutilization, most manufacturers recom-
mend just a single use (2). Several authors have conclud-
ed that the use of sterilization procedures alone for the 
treatment of reused abutments might not be sufficient, 
and recommend previous cleaning protocols to detach 
incrusted material before a re-sterilization step (3)
Different strategies have been assayed to minimize 
the consequences of reutilization, including the use of 
cheaper materials, such as glass-fiber (4,5), and differ-
ent cleaning processes (6-8).
The aim of this work was to explore the eventual surviv-
al of microorganisms on sterilized abutments, as well as 
to explore to what extent bacteria found on abutments 
could be the direct cause of implant failures. There is a 
high proportion of initial implant success, and later fail-
ure is normally attributed to biomechanical or micro-
biological causes (2-9). Thus, our aim can be extended 
to answer a new question: To what extent does biologi-
cal detritus on reused abutments contribute to implant 
failure? 
Material and Methods
A total of 55 healing abutments previously used in one 
or more patients during the passive osseointegration pe-
Results: No bacterial growth was detected on any of the 58 cultured abutments, indicating that the sterilization was 
completely satisfactory in terms of removal of live bacteria or spores. Nevertheless, significant amounts of organic 
carbon may still be recovered (up to 125,31 µg/abutment) after they have been sterilized. 
Conclusions: Significant amounts of the bioburden remained adhered to the surfaces in spite of the cleaning and ster-
ilization procedures. Taking into account our results and data from other authors, the presence of infectious particles 
on the reused healing abutments such as prions cannot be ruled out.
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riod of three to six months were provided by eight dif-
ferent dental clinics of Barcelona, Spain. Once retired, 
the healing abutments were processed for cleaning and 
disinfection by immersion in enzymatic detergent for 
2-5 minutes,  followed by an ultrasound bath at 40-
45ºC for 10-15’ and finally dried. They were placed in 
heat-sealed sterilization bags (3M Steri-Dual ECO, Ref: 
8652). The sterilization was carried out with a Class B 
autoclave in a program for metals (134ºC, 12 minutes, 
2.1 bar pressure).
-Sample culture
Each healing abutment was removed from the steriliza-
tion bag and submerged in a rich microbiological me-
dium (10 mL of Brain Heart Infusion broth (BHI) Shar-
lau, Sentmenat, Spain) in 18x180 mm test tubes under 
strict aseptic conditions. Two control groups were pre-
pared: the first consisted of three new (unused) healing 
abutments (Nobel Biocare, Sweeden; Ref: 33445 BmK 
Syst RP; Sterilized using irradiation); and the second, of 
just the bacteriological medium (lacking an abutment). 
The tubes were incubated for 10 days, at 37°C under 
a 5% CO2 atmosphere and examined visually daily for 
turbidity. At the end of the experiment, the tubes were 
examined again and Petri dishes containing BHI agar 
(BHIA) and Columbia Blood agar (Sharlau, Sentmenat, 
Spain) were inoculated with 100 µl of the medium from 
each tube to test for sterility. The contents of each tube 
were centrifuged at 2.500 rpm and sediment was Gram 
stained and observed at 1000 x’ to discard the presence 
of non-cultivable microorganisms (Fig. 1).
-Determination of Total Organic Carbon (TOC)
Moreover, to determine the presence of remaining or-
ganic material after the cleaning and sterilizing treat-
ments, the bioburden present in the used abutments was 
determined by measuring total organic carbon (TOC) 
present.
A different stock of 10 previously used healing abut-
ments, cleaned and sterilized, were submerged in 10 
Eppendorf flasks with 1.5 ml Milli-Q water and soni-
cated in an ultrasonic bath for 1 hour.
A volume of 15 ml Milli-Q water was used as blank 
control.
TOC was measured using a multi N/C® 3100 analyzer 
(Analytic Jena, Jena, Germany).




None of the 55 used abutments processed in the micro-
biological experiments produced obvious visible turbid-
ity in the medium, although in some cases micropar-
ticulated material appeared after 24 hours of incubation 
(first examination) and remained throughout the incuba-
tion period. However, it should be stated that in none 
of these samples did the turbidity increase over this 
period. Moreover, after 10 days of incubation and the 
subsequent inoculation of aliquots of the liquid medium 
onto BHIA and Columbia Blood agar plates, no bacte-
rial growth was detected on any of them, indicating that 
the sterilization of the used abutments was complete-
ly satisfactory in terms of removal of live bacteria or 
Fig. 1: Microbiological cultures. 4 tubes containing 10 ml  of Brain 
Hearth broth, the left one been the negative control with only me-
dium and the other ones with 3 healing abutments, after incubation 
at 37°C for 10 days under 5%  CO2 atmosphere. No differences in 
turbidity were observed.
Blank Abutments
Parameter Value Sd. Deviation Value Sd. Deviation
TOC 4,09 µg/abutment 125,31 µg/abutment
IC 0,81 µg/abutment 0,1 1,07 µg/abutment 0,69
TC 4,90 µg/abutment 0,05 126,39 µg/abutment 108,45
Table 1: Values of Carbon adhered to used abutments. TOC:  Total Organic Carbon, IC: Inorganic Carbon , TC: Total 
Carbon (TC = IC+TOC).
spores. In some cases, the Gram stain examination of 
the smear was difficult to interpret because of the pres-
ence of abundant debris stained with a pink color.
-Determination of Total Organic Carbon (TOC)
The TOC determinations of the abutments were much 
higher than expected (Table 1). It is worth noting that 
a significant amount of organic material was recovered 
from the used abutments, indicating that it had remained 
adhered to the surfaces of the abutments. Since there is 
a huge difference between the organic carbon content 
of the abutments and the Milli-Q water used for sub-
merging the abutments prior to sonication, our results 
demonstrate that significant amounts of the bioburden 
remained adhered to the surfaces.
Discussion 
Although no living cells survive the autoclaving, it is 
well known that many molecules as well as epithelial 
and blood cells and bacterial fractions may retain cer-
tain properties after the sterilization procedure. The 
organic material found on the reused abutments would 
come from the patient in which the abutment was con-
nected to. Subsequently, it may either affect cell ad-
hesion and the effective spreading and attachment of 
epithelium and connective tissue(2,10), or promote in-
flammatory processes in a hypothetical re-receptor. The 
proteins and amino acids that can remain adhered to ti-
tanium are extremely difficult to remove.
Sterilization of previously used or intentionally con-
taminated healing abutments is a safe procedure to 
eliminate bacteria, virus and fungi as different studies 
had demonstrated previously (1) . 
Given that recent studies suggest that the sterilization of 
the healing abutments does not eliminate all the biolog-
ical debris, the placement of contaminated abutments 
could be associated with the development of peri-im-
plant disease allowing a good place to adhere and grow 
(11-13).
All this represents different kinds of health risk for the 
second user. One of these risks may be illustrated by 
considering prions. Biological debris could act as an ef-
fective vector for the transmission of prions. These infec-
tious proteinaceous agents can cause neurodegenerative 
diseases that in humans include Kuru, Creutzfeldt-Ja-
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kob disease, Gerstmann-Straussler-Scheinker disease, 
and Fatal Familial Insomnia. In principle, the measure-
ment of “viability” when considering prions should be 
regarded as the measurement of the maintenance of in-
fectivity. Despite only a few laboratories in the world 
are undertaking experimental work with prions, notably 
that of Stanley B. Prusiner (Nobel Prize in Physiology 
or Medicine, 1997), the work has led to several major 
concerns (14). The first and most relevant in the cur-
rent context is that prions need to be completely inacti-
vated using harsher conditions than those used against 
bacteria and viruses. To ensure prion inactivation, the 
thermal sterilization should be combined with chemi-
cal treatment. It would appear that procedures used for 
routine sterilization of surgical instruments cannot in-
activate prions (15,16), which already led to the devel-
opment of new and more stringent recommendations for 
reprocessing instruments and these should eventually 
be applied to abutments (17). This has been reinforced 
by the discovery that prions that are responsible for 
bovine spongiform encephalitis (BSE) can be up to 1 
million times more difficult to inactivate than the most 
commonly used hamster prions; thus, one cannot ex-
clude the possibility that human prions are also much 
more resistant than the laboratory prions (10). These 
recommendations are based on conventional autoclav-
ing (121ºC) combined with chemical attack; this may be 
achieved by autoclaving in the presence of 1 M sodium 
hydroxide, or by soaking in 2% bleach for 1 h. Such 
treatments are extremely corrosive and may cause ir-
reversible damage to the surface of abutments (18).
Prevalence of asymptomatic Creutzfeldt-Jakob disease 
(CJD) in UK population in people born from 1941 to 
1985 is 1:2000 and prion iatrogenic transmission (blood 
transfusions, organ transplants and surgical instrumen-
tation) is therefore possibility. Another source of prions 
could be bovine bone substitutes used widely for bone 
regeneration after or simultaneously to the dental im-
plant placement. These materials keep some proteins, 
their manufacturing processes are not guaranty to the 
inactivation of the prion, and in consequence, Kim et al. 
(19) suggest abolishing the use of bovine bone.
The presence of organic carbon reported in our study 
means that organic material originating in the patient is 
adhered to the surface and, subsequently, the presence 
of prions cannot be ruled out. In conclusion, we believe 
that, despite costs, the practice of reusing implant abut-
ments should be abandoned, since it cannot be demon-
strated to be safe enough. 
Further studies trying to identify the source of the or-
ganic carbon adhered in the abutments are needed. In 
addition, it is worth elucidating if there could be any 
safe procedure to effectively remove all the organic 
material present in the titanium surfaces of the reused 
healing abutments.
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